We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Galderma Drops MetroGel Patent Suit V. Tolmar

Law360 (April 24, 2009, 12:00 AM EDT) -- Swiss dermatological drugmaker Galderma SA has dropped its patent infringement suit against rival pharmaceutical company Tolmar Inc. over rosacea treatment MetroGel.

A judge for the U.S. District Court for the District of Colorado approved Galderma’s voluntary dismissal on Thursday, tossing the complaint less than two months after it was filed.

A representative for Galderman could not immediately be reached to elaborate on the reason for the dismissal.

Galderma hit Colorado-based Tolmar with the lawsuit on March 4 after Tolmar submitted an abbreviated new drug application to...
To view the full article, register now.